{
  "actions": [
    {
      "acted_at": "1991-11-25", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1992-01-14", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health and the Environment", 
      "text": "Referred to the Subcommittee on Health and the Environment.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3930-102", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health and Environment", 
      "subcommittee_id": "04"
    }
  ], 
  "congress": "102", 
  "cosponsors": [
    {
      "district": "8", 
      "name": "Dellums, Ronald V.", 
      "sponsored_at": "1992-03-26", 
      "state": "CA", 
      "thomas_id": "00284", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "17", 
      "name": "Evans, Lane", 
      "sponsored_at": "1992-03-26", 
      "state": "IL", 
      "thomas_id": "00361", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Foglietta, Thomas M.", 
      "sponsored_at": "1992-03-26", 
      "state": "PA", 
      "thomas_id": "00395", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Hochbrueckner, George J.", 
      "sponsored_at": "1992-03-26", 
      "state": "NY", 
      "thomas_id": "00546", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Jones, Walter B.", 
      "sponsored_at": "1992-03-26", 
      "state": "NC", 
      "thomas_id": "00611", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "22", 
      "name": "Murphy, Austin J.", 
      "sponsored_at": "1992-03-26", 
      "state": "PA", 
      "thomas_id": "00841", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "4", 
      "name": "Rahall, Nick J., II", 
      "sponsored_at": "1992-03-26", 
      "state": "WV", 
      "thomas_id": "00940", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "3", 
      "name": "Wyden, Ron", 
      "sponsored_at": "1992-03-26", 
      "state": "OR", 
      "thomas_id": "01247", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1991-11-25", 
  "number": "3930", 
  "official_title": "To revise the orphan drug exclusivity provisions of the Federal Food, Drug, and Cosmetic Act.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "10", 
    "name": "Studds, Gerry E.", 
    "state": "MA", 
    "thomas_id": "01121", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1991-11-25", 
  "subjects": [
    "Drug industry", 
    "Drugs", 
    "Government paperwork", 
    "Licenses", 
    "Orphan drugs"
  ], 
  "subjects_top_term": "Drugs", 
  "summary": {
    "as": "Introduced", 
    "date": "1991-11-25", 
    "text": "Amends provisions of the Federal Food, Drug, and Cosmetic Act (FDCA) relating to drugs for rare diseases or conditions (commonly referred to as orphan drugs) to require the approval of an application under FDCA new drug provisions, a certification under FDCA antibiotic drug provisions, or a license under provisions of the Public Health Service Act regulating biologic products when the current holder of such an application, certification, or license has had: (1) cumulative dollar sales of the drug exceeding specified amounts; and (2) cumulative research and development costs for the drug not exceeding certain amounts."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "To revise the orphan drug exclusivity provisions of the Federal Food, Drug, and Cosmetic Act.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:14:02-05:00"
}